ID   TZM-bl
AC   CVCL_B478
SY   TZM; JC53-bl; JC53BL-13; JC.53bl-13; JC53-bl clone 13
DR   BTO; BTO:0005059
DR   ChEMBL-Cells; CHEMBL3307662
DR   ChEMBL-Targets; CHEMBL614612
DR   HIVReagentProgram; ARP-8129
DR   PubChem_Cell_line; CVCL_B478
DR   Wikidata; Q54973492
RX   PubMed=18842727;
RX   PubMed=19474095;
CC   Population: African American.
CC   Transformant: NCBI_TaxID; 333761; Human papillomavirus type 18 (HPV18).
CC   Misspelling: TZM-b1; Note=Occasionally.
CC   Derived from site: In situ; Uterus, cervix; UBERON=UBERON_0000002.
DI   NCIt; C27677; Human papillomavirus-related cervical adenocarcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0030 ! HeLa
SX   Female
AG   30Y6M
CA   Cancer cell line
DT   Created: 06-06-12; Last updated: 05-10-23; Version: 20
//
RX   PubMed=18842727; DOI=10.1128/JVI.01726-08;
RA   Takeuchi Y., McClure M.O., Pizzato M.;
RT   "Identification of gammaretroviruses constitutively released from cell
RT   lines used for human immunodeficiency virus research.";
RL   J. Virol. 82:12585-12588(2008).
//
RX   PubMed=19474095; DOI=10.1128/JVI.00709-09;
RA   Platt E.J., Bilska M., Kozak S.L., Kabat D., Montefiori D.C.;
RT   "Evidence that ecotropic murine leukemia virus contamination in TZM-bl
RT   cells does not affect the outcome of neutralizing antibody assays with
RT   human immunodeficiency virus type 1.";
RL   J. Virol. 83:8289-8292(2009).
//